Tag: data

BASSETT, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) reported today its results of operations for its second quarter ended May 31, 2025.

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) and Black Bear and Fond Du Luth Casinos are thrilled to announce their strategic partnership that is set to transform the gaming and hospitality landscape in the Minnesota market. This dynamic collaboration represents an exciting fusion of advanced technology and exceptional guest experiences, with Black Bear and Fond Du Luth Casinos leading the charge. By leveraging QCI's cutting-edge data analytics platform, the partnership aims to redefine how casinos operate, providing unparalleled insights into player behavior, enhancing operational efficiency, and delivering personalized guest experiences like never before. This bold move positions Black Bear and Fond Du Luth Casinos at the forefront of innovation, setting a new standard in how technology can drive the future of gaming and hospitality.

HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") plans to release its second quarter 2025 results on Wednesday, July 23, 2025, after the market closes. In conjunction with the release, Crown Castle has scheduled a conference call for Wednesday, July 23, 2025, at 5:30 p.m. eastern time.

Talent concentrates in global tech hubs as AI reshapes workforce demand and location strategy

Data from Orbit and Cosmic studies expected around the end of the year

Daix (France), New York City (New York, United States), July 9, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced a leadership transition with the appointment of Jason Campagna, MD, PhD, as President of Research and Development (“R&D”) and Chief Medical Officer (“CMO”) and Martine Zimmermann, PharmD, as Executive Vice President (“EVP”) of Regulatory Affairs and Quality Assurance.